Present and future of metal nanoparticles in tumor ablation therapy

Lou, Wenjing; Xie, Liting; Xu, Lei; Xu, Min; Xu, Fan; Zhao, Qiyu; Jiang, Tianan

doi:10.1039/d3nr04362b

Cited by 3 publications

(1 citation statement)

References 252 publications

(349 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 22 , 26 NPs can also carry multiple drugs and can overcome the problem of drug resistance through combination therapy. 27 , 28 , 29 , 30 …”

Section: Introductionmentioning

confidence: 99%

Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives

Liu,

Yang,

et al. 2024

CNS Neurosci Ther

View full text Add to dashboard Cite

Gliomas are the most common primary tumors of the central nervous system, with glioblastoma multiforme (GBM) having the highest incidence, and their therapeutic efficacy depends primarily on the extent of surgical resection and the efficacy of postoperative chemotherapy. The role of the intracranial blood–brain barrier and the occurrence of the drug‐resistant gene O6‐methylguanine‐DNA methyltransferase have greatly limited the efficacy of chemotherapeutic agents in patients with GBM and made it difficult to achieve the expected clinical response. In recent years, the rapid development of nanotechnology has brought new hope for the treatment of tumors. Nanoparticles (NPs) have shown great potential in tumor therapy due to their unique properties such as light, heat, electromagnetic effects, and passive targeting. Furthermore, NPs can effectively load chemotherapeutic drugs, significantly reduce the side effects of chemotherapeutic drugs, and improve chemotherapeutic efficacy, showing great potential in the chemotherapy of glioma. In this article, we reviewed the mechanisms of glioma drug resistance, the physicochemical properties of NPs, and recent advances in NPs in glioma chemotherapy resistance. We aimed to provide new perspectives on the clinical treatment of glioma.

show abstract

“… 22 , 26 NPs can also carry multiple drugs and can overcome the problem of drug resistance through combination therapy. 27 , 28 , 29 , 30 …”

Section: Introductionmentioning

confidence: 99%